The quick ratio is a stricter test of whether a company can pay the bills due within a year, counting only assets that are already cash or close to it. It is cash, marketable securities and receivables divided by current liabilities, shown as a multiple, with both amounts in the table. It is the current ratio with inventory and other assets that take longer to turn into cash removed, so it is never higher than the current ratio. A company that does not report one of the inputs has no point for that date rather than an estimated one. Quarterly points use quarter-end balances; annual points use fiscal-year-end balances.
Aardvark Therapeutics, Inc. quick ratio for the quarter ending 2026-06-30 was 11.57, a 15.92% decline year-over-year.
Aardvark Therapeutics, Inc. quick ratio for the quarter ending 2026-03-31 was 7.86, a 68.95% decline year-over-year.
Aardvark Therapeutics, Inc. quick ratio for the quarter ending 2025-12-31 was 10.43, a 30.23% decline year-over-year.
Aardvark Therapeutics, Inc. quick ratio for the quarter ending 2025-09-30 was 11.77.
Aardvark Therapeutics, Inc. quick ratio for fiscal 2025 was 10.43, a 30.23% decline from fiscal 2024.
Aardvark Therapeutics, Inc. quick ratio for fiscal 2024 was 14.95.